NDLI: 5-HT$_{6/7}$ Receptor Antagonists Facilitate Dopamine Release in the Cochlea via a GABAergic Disinhibitory Mechanism

Content Provider	Springer Nature Link
Author	Doleviczényi, Zoltán Vizi, E. Sylvester Gacsályi, István Pallagi, Katalin Volk, Balázs Hársing, László G. Halmos, György Lendvai, Balázs Zelles, Tibor
Copyright Year	2008
Abstract	In humans, serotonin (5-HT) has been implicated in numerous physiological and pathological processes in the peripheral auditory system. Dopamine (DA), another transmitter of the lateral olivocochlear (LOC) efferents making synapses on cochlear nerve dendrites, controls auditory nerve activation and protects the sensory nerve against overactivation. Using in vitro microvolume superfusion techniques we tested 5-HT$_{6}$ and 5-HT$_{7}$ receptor antagonists whether they can influence dopamine (DA) release from the guinea-pig cochlea in control and in ischemic conditions using currently available and new 5-HT$_{6}$ and 5-HT$_{7}$ antagonists and mixed antagonists, which were synthesized and characterized for the current study. While the 5-HT$_{7}$ antagonist SB-258719 was ineffective, SB-271046, which blocks the 5-HT$_{6}$ receptor, caused a significant increase in cochlear DA release what is contradictory with the excitatory nature of this type of receptor. Moreover, the mixed 5-HT$_{6/7}$ antagonist EGIS-12233 induced an even more pronounced increase in the resting DA release. To understand why the block of an excitatory receptor results in an increase instead of a decrease in function, we investigated the possible involvement of an indirect neural mechanism through an inhibitory system. In the presence of the GABA$_{A}$ receptor blocker bicuculline, EGIS-12233 failed to increase the release of DA, suggesting that the serotonin receptor modulation of DA release from the lateral olivocochlear efferents in the cochlea was produced indirectly by decreasing the GABAergic inhibitory tone on dopaminergic nerve endings. The mixed 5-HT$_{7}$/D$_{4}$ receptor antagonist EGIS-11983 significantly increased both the stimulation-evoked and the resting DA release, while the selective D4 blocker L-741,741 alone had no significant effect. Ischemia, simulated by oxygen and glucose deprivation from the perfusion solution had no action on the effect of the drugs. Drugs that can increase the release of DA from LOC terminals in the cochlea may have a role in the treatment of sensorineural hearing loss.
Starting Page	2364
Ending Page	2372
Page Count	9
File Format	PDF
ISSN	03643190
Journal	Neurochemical Research
Volume Number	33
Issue Number	11
e-ISSN	15736903
Language	English
Publisher	Springer US
Publisher Date	2008-07-29
Publisher Place	Boston
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Cochlea Dopamine release Serotonin 5-HT$_{6}$ 5-HT$_{7}$ Neuroprotection GABAergic innervation Neurology Biochemistry Neurosciences
Content Type	Text
Resource Type	Article
Subject	Medicine Biochemistry Cellular and Molecular Neuroscience

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Modeling tardive dyskinesia: Predictive 5-HT$_{2C}$ receptor antagonist treatment

From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT$_{3}$ Receptor Antagonists

A 5-HT$_{7}$ Heteroreceptor-Mediated Inhibition of [$^{3}$H]Serotonin Release in Raphe Nuclei Slices of the Rat: Evidence for a Serotonergic–Glutamatergic Interaction

5-HT$_{7}$ Receptors Are Involved in Neurogenic Dural Vasodilatation in an Experimental Model of Migraine

5-HT$_{7}$ Receptors Are Not Involved in Neuropeptide Release in Primary Cultured Rat Trigeminal Ganglion Neurons

Dopamine D$_{1}$ Receptor Gene Expression Studies in Unilateral 6-Hydroxydopamine-Lesioned Parkinson’s Rat: Effect of 5-HT, GABA, and Bone Marrow Cell Supplementation

Linoleic Acid Derivative DCP-LA Ameliorates Stress-Induced Depression-Related Behavior by Promoting Cell Surface 5-HT$_{1A}$ Receptor Translocation, Stimulating Serotonin Release, and Inactivating GSK-3β

The Central 5-HT$_{3}$ Receptor in CNS Disorders

Distribution of Serotonin Receptor of Type 6 (5-HT$_{6}$) in Human Brain Post-mortem. A Pharmacology, Autoradiography and Immunohistochemistry Study

5-HT$_{6/7}$ Receptor Antagonists Facilitate Dopamine Release in the Cochlea via a GABAergic Disinhibitory Mechanism

Similar Documents

Modeling tardive dyskinesia: Predictive 5-HT$_{2C}$ receptor antagonist treatment

From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT$_{3}$ Receptor Antagonists

A 5-HT$_{7}$ Heteroreceptor-Mediated Inhibition of [$^{3}$H]Serotonin Release in Raphe Nuclei Slices of the Rat: Evidence for a Serotonergic–Glutamatergic Interaction

5-HT$_{7}$ Receptors Are Involved in Neurogenic Dural Vasodilatation in an Experimental Model of Migraine

5-HT$_{7}$ Receptors Are Not Involved in Neuropeptide Release in Primary Cultured Rat Trigeminal Ganglion Neurons

Dopamine D$_{1}$ Receptor Gene Expression Studies in Unilateral 6-Hydroxydopamine-Lesioned Parkinson’s Rat: Effect of 5-HT, GABA, and Bone Marrow Cell Supplementation

Linoleic Acid Derivative DCP-LA Ameliorates Stress-Induced Depression-Related Behavior by Promoting Cell Surface 5-HT$_{1A}$ Receptor Translocation, Stimulating Serotonin Release, and Inactivating GSK-3β

The Central 5-HT$_{3}$ Receptor in CNS Disorders

Distribution of Serotonin Receptor of Type 6 (5-HT$_{6}$) in Human Brain Post-mortem. A Pharmacology, Autoradiography and Immunohistochemistry Study

5-HT$_{6/7}$ Receptor Antagonists Facilitate Dopamine Release in the Cochlea via a GABAergic Disinhibitory Mechanism